INTERVENT Health AI Names James F. Hughes Chief Executive Officer
Related: INTERVENT International and Brand Engagement Network Launch INTERVENT Health AI, Inc. (June 11, 2026)
August 24, 2026—INTERVENT Health AI, Inc., the joint venture between Brand Engagement Network, Inc. (NASDAQ: BNAI) ("BEN") and INTERVENT International, LLC ("INTERVENT"), has named James F. Hughes as Chief Executive Officer, effective August 1, 2026. BEN referenced the appointment during its second-quarter earnings update on August 20, 2026.
As CEO, Hughes is tasked with leading the company’s mission to deliver next-generation, AI-driven health solutions at enterprise scale, globally, while meeting individuals where they are in their own healthcare journey. Under his leadership, INTERVENT Health AI will advance technology designed to expand access, improve quality, and control cost and risk — for health plans, employers, and healthcare stakeholders, and for the individuals and members they ultimately serve. Hughes brings more than 25 years of healthcare industry experience, built on strategic sales leadership, enterprise partnerships, and deep command of healthcare risk, sector complexity, data analytics, and consultation.
Before his appointment as CEO, Hughes held senior sales and business development leadership roles across the healthcare technology and benefits sectors, where he consistently ranked among top performers and helped develop innovative solutions that have since become industry standards.
As CEO of INTERVENT Health AI, Hughes is focused on scaling a global platform of AI-powered health solutions that go well beyond risk analytics and prediction — spanning access, engagement, quality, and cost control — with a clear mandate to deliver measurable outcomes for plan sponsors, members, and enterprise partners worldwide.
He holds a Bachelor of Science in Finance from the University of South Florida and is professionally licensed in Florida.
“James’s background in enterprise healthcare sales and risk analytics makes him well-suited to lead INTERVENT Health AI’s commercialization efforts,” said Tyler Luck, Chief Executive Officer of BEN. “The goal isn’t to replace the human health coach — it’s to use AI to extend the reach, consistency, and availability of the coaching itself, helping more people access evidence-based support at greater scale. James’s experience bridging enterprise healthcare relationships with data-driven risk analytics makes him the right leader to bring that vision to a multitude of verticals, including employers, payors, providers, hospital systems, and health plans.”
About INTERVENT Health AI
INTERVENT Health AI is a 50/50 joint venture between BEN and INTERVENT, launched in June 2026 to combine more than 25 years of INTERVENT’s clinically validated health coaching methodologies — which have served more than two million individuals and are supported by over 120 published scientific abstracts and manuscripts — with BEN’s conversational AI technology. The venture is designed to help employers, health plans, and healthcare systems scale evidence-based coaching and chronic disease management programs through AI-powered engagement, extending the reach and consistency of proven coaching programs rather than replacing the human coach.
About INTERVENT International
INTERVENT International is a physician-led, global provider of digital health coaching and population health management solutions. For more information, visit interventhealth.com.
About Brand Engagement Network, Inc.
Brand Engagement Network, Inc. (“BEN”) builds secure, enterprise-grade artificial intelligence for the engagement layer of AI — where human intent is transformed into intelligent interactions, automated workflows, and real-world outcomes. Powered by BEN’s proprietary Engagement Language Model (ELM™), BEN’s technology enables conversational AI interactions that connect human intent to organizational data, workflows, and real-world outcomes. BEN’s AI operates within secure closed-loop environments using approved organizational data and built-in governance and compliance controls. Trusted by organizations operating in regulated and high-impact industries, BEN helps bring AI into real operational settings where engagement drives outcomes and accountability matters. For more information, visit www.brandengagementnetwork.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the anticipated commercialization and growth of INTERVENT Health AI. These statements are based on current expectations and assumptions and are subject to risks and uncertainties, including those described in BEN’s filings with the Securities and Exchange Commission, that could cause actual results to differ materially. BEN undertakes no obligation to update these statements except as required by law.
Media and Investor Relations Contacts
Media
Investor Relations
